Sign in

CIK 0001980845 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

enGene Therapeutics Inc.

Sign in to watch
Ticker
ENGN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Oct 31
Incorporated
Canada (Federal Level)
Entity type
operating
Phone
(514) 332-4888
Business address
4868 RUE LEVY, SUITE 220, SAINT-LAURENT, Quebec, Canada
Former names
enGene Holdings Inc.

Securities

  • ENGN Common Stock Nasdaq
  • ENGNW Warrants Nasdaq
  1. 8-K Event Results of operations
  2. SCHEDULE 13G Stake Statement of Beneficial Ownership
  3. SCHEDULE 13G Stake Statement of Beneficial Ownership
  4. 8-K Event Material agreement · Regulation FD disclosure
  5. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  6. 424B5 Offering Prospectus
  7. 424B5 Offering Prospectus
  8. 8-K Event Regulation FD disclosure · Other events
  9. 8-K Event Executive or director change
  10. 8-K/A Event Executive or director change
  11. 4 Derivatives Options or other derivatives
  12. 3 Insider Initial Statement of Ownership
  13. 8-K Event Regulation FD disclosure
  14. S-8 Other Securities Offered to Employees in Benefit Plans
  15. 10-Q Report Quarterly Report
  16. 8-K Event Results of operations
  17. 8-K Event Regulation FD disclosure · Other events
  18. 4 Derivatives Options or other derivatives
  19. 3 Insider Initial Statement of Ownership
  20. 4 Derivatives Options or other derivatives

Page 4 of 14 · 268 filings